Order Article Reprints

Vocka M, Zimovjanova M, Bielcikova Z, Tesarova P, Petruzelka L, Mateju M, Krizova L, Kotlas J, Soukupova J, Janatova M, et al. Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers. Cancers. 2019; 11(6):738. https://doi.org/10.3390/cancers11060738

Vocka, Michal, Martina Zimovjanova, Zuzana Bielcikova, Petra Tesarova, Lubos Petruzelka, Martin Mateju, Ludmila Krizova, Jaroslav Kotlas, Jana Soukupova, Marketa Janatova, and et al. 2019. "Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers" Cancers 11, no. 6: 738. https://doi.org/10.3390/cancers11060738

Vocka, M., Zimovjanova, M., Bielcikova, Z., Tesarova, P., Petruzelka, L., Mateju, M., Krizova, L., Kotlas, J., Soukupova, J., Janatova, M., Zemankova, P., Kleiblova, P., Novotny, J., Konopasek, B., Chodacka, M., Brychta, M., Sochor, M., Smejkalova-Musilova, D., Cmejlova, V., ... Kleibl, Z. (2019). Estrogen Receptor Status Oppositely Modifies Breast Cancer Prognosis in BRCA1/BRCA2 Mutation Carriers Versus Non-Carriers. Cancers, 11(6), 738. https://doi.org/10.3390/cancers11060738